Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a chilean public hospital Experiencia de trombolisis sistematizada en infarto cerebral agudo en un hospital público de chile
Author
dc.contributor.author
Figueroa-Reyes, Tatiana
Author
dc.contributor.author
Sáez, David M.
Author
dc.contributor.author
Mansilla, Eloy L.
Author
dc.contributor.author
Sánchez, Rodrigo V.
Author
dc.contributor.author
Nogales Gaete, Jorge
Author
dc.contributor.author
Delgado, Iris B.
Admission date
dc.date.accessioned
2019-03-11T13:03:09Z
Available date
dc.date.available
2019-03-11T13:03:09Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 139, Issue 9, 2018, Pages 1118-1127
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.other
10.4067/S0034-98872011000900002
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165486
Abstract
dc.description.abstract
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile to private clinics. Recently, at year 2009, we have implemented this treatment in a public hospital. Aim: To describe the results of treatment of acute ischemic stroke with t-PA in a public hospital in Chile. Material and Methods: Prospective analysis of all eligible patients with acute ischemic stroke that were admitted within 4 hours of its onset and had no contraindications for thrombolysis. Results: In an eight months period, a total of 19 intravenous thrombolyses were performed in 12 males and seven females aged 28 to 79 years old. The mean lapse between onset of symptoms and onset of thrombolysis was 190 ± 57 min. Results were favorable, according to Rankin and National Institute of Health Stroke scales. Ninety days after treatment, 63% of patients had minimal or
Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a chilean public hospital Experiencia de trombolisis sistematizada en infarto cerebral agudo en un hospital público de chile